Key result
Leadless pacemaker implantation during pregnancy safely resolves symptoms with low fetal radiation of ~1.4 mGy.
Why the study?
Use of leadless pacemakers during pregnancy remains very limited due to concerns related to radiation exposure.
Case Report (n=1)
No
Leadless pacemaker implantation during pregnancy is feasible and results in very low fetal radiation exposure when dose-reduction strategies are carefully implemented.
Answers are grounded in this paper and cite their sources.
Supports feasibility of leadless pacing in mid-pregnancy with low fetal dose; hypothesis-generating and requires prospective data before wider use.
Leadless pacemakers offer an alternative to conventional pacing by eliminating lead- and pocket-related complications. However, their use during pregnancy remains very limited due to concerns related to radiation exposure. We describe the clinical experience of a 17-week pregnant patient who presented with episodes of dizziness, profound weakness, and syncope. Further evaluation revealed second-degree atrioventricular block, Mobitz type II, and transient third-degree atrioventricular block documented by Holter monitoring, indicating the need for permanent pacing. The patient underwent implantation of a Micra AV (Medtronic, USA) leadless pacemaker under fluoroscopic guidance using optimized radiation safety protocols. The estimated fetal absorbed dose was 1.4 mGy, well below reported thresholds for deterministic effects and associated with a very low additional radiation risk compared with background risks of congenital malformations and childhood cancer. The maternal effective dose was 15 mSv. Post-procedure follow-up demonstrated complete symptom resolution, an uncomplicated continuation of pregnancy, and delivery of a healthy infant. This case illustrates the practical feasibility of leadless pacemaker implantation during pregnancy when careful radiation minimization strategies are applied and adds real-world experience to the limited data available for critical pacing indications in pregnant patients.
No takes yet. Share an insight, caveat, or question.
Abdrakhmanov et al. (2026) conducted a case report in High-degree atrioventricular block during pregnancy (n=1). Leadless pacemaker implantation (Micra AV) under fluoroscopic guidance was evaluated on Fetal radiation exposure (estimated conceptus absorbed dose) and clinical pacing outcome. Leadless pacemaker implantation at 17 weeks' gestation was successfully performed with an estimated fetal absorbed dose of 1.4 mGy, resulting in maternal symptom resolution and delivery of a healthy infant.
Synapse has enriched 10 related papers. Consider them for comparative context: